Cargando…

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Liver fibrosis reflects tissue scarring in the liver due to the accumulation of excessive extracellular matrix in response to chronically persistent liver injury. Hepatocyte cell death can trigger capillarization of liver sinusoidal endothelial cells, stimulation of immune cells including macrophage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Odagiri, Naoshi, Matsubara, Tsutomu, Sato-Matsubara, Misako, Fujii, Hideki, Enomoto, Masaru, Kawada, Norifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273638/ https://www.ncbi.nlm.nih.gov/pubmed/33317250 http://dx.doi.org/10.3350/cmh.2020.0187

Ejemplares similares

Non-heat-stressed Method to Isolate Hepatic Stellate Cells From Highly Steatotic Tumor-bearing Liver Using CD49a
por: Cheng, Yi, et al.
Publicado: (2022)

High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use
por: Tamori, Akihiro, et al.
Publicado: (2020)

Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease
por: Matsumoto, Yoshinari, et al.
Publicado: (2023)

New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma
por: Kawamura, Etsushi, et al.
Publicado: (2023)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
por: Tamori, Akihiro, et al.
Publicado: (2016)

Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling
por: Sato-Matsubara, Misako, et al.
Publicado: (2017)

Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21
por: Kawamura, Etsushi, et al.
Publicado: (2022)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment
por: Kozuka, Ritsuzo, et al.
Publicado: (2022)

The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases
por: Fujii, Hideki, et al.
Publicado: (2021)

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
por: Uchida‐Kobayashi, Sawako, et al.
Publicado: (2022)

Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma
por: Dong, Minh Phuong, et al.
Publicado: (2020)

Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
por: Kotani, Kohei, et al.
Publicado: (2023)

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization
por: Odagiri, Naoshi, et al.
Publicado: (2020)

Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice
por: Thi Thanh Hai, Nguyen, et al.
Publicado: (2018)

Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance?
por: Enomoto, Masaru, et al.
Publicado: (2022)

Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis
por: Fujii, Hideki, et al.
Publicado: (2021)

Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms
por: Huu Hoang, Truong, et al.
Publicado: (2022)

Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed
por: Nonomura, Ayami, et al.
Publicado: (2021)

Nitric Oxide Derived from Cytoglobin-Deficient Hepatic Stellate Cells Causes Suppression of Cytochrome c Oxidase Activity in Hepatocytes
por: Okina, Yoshinori, et al.
Publicado: (2023)

Induction of microRNA-214-5p in human and rodent liver fibrosis
por: Iizuka, Masashi, et al.
Publicado: (2012)

Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry
por: Yoshizato, Katsutoshi, et al.
Publicado: (2022)

Present State and Future Prospects of Pediatric Liver Transplantations
por: Kasahara, Mureo, et al.
Publicado: (2018)

Effect of Caffeine-Containing Beverage Consumption on Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: A Hospital-Based Cohort Study
por: Sasaki, Yachiyo, et al.
Publicado: (2013)

Putting “sticky notes” on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study
por: Fujii, Hideki, et al.
Publicado: (2016)

Hepatitis B virus infection and alcohol consumption
por: Iida-Ueno, Ayako, et al.
Publicado: (2017)

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy
por: Yoshida, Kanako, et al.
Publicado: (2021)

Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients–Relationship to smoking and alcohol
por: Matsuura, Tomoka, et al.
Publicado: (2020)

The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B
por: Suoh, Maito, et al.
Publicado: (2020)

Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2017)

Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C
por: Takemura, Kazuya, et al.
Publicado: (2020)

Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion
por: Hieu, Vu Ngoc, et al.
Publicado: (2022)

Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
por: Iwata, Yasunori, et al.
Publicado: (2021)

Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis
por: Kawada, Norifumi
Publicado: (2004)

The Albumin-bilirubin Score Detects Changes in the Liver Function during Treatment for Budd-Chiari Syndrome: A Retrospective Observational Study
por: Kageyama, Ken, et al.
Publicado: (2021)

Successful Transcatheter Arterial Embolization for Hemothorax from a Spontaneous Rupture of Hepatocellular Carcinoma Metastasis to the Chest Wall in an Elderly Patient
por: Suoh, Maito, et al.
Publicado: (2021)

A case of primary small cell carcinoma of the liver that was treated with chemotherapy
por: Morikawa, Hiroyasu, et al.
Publicado: (2008)

Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
por: Ohtani, Naoko, et al.
Publicado: (2019)

Anti-fibrotic Treatment for Pulmonary Fibrosis Induced by COVID-19: A Case Presentation
por: Sakızcı Uyar, Bahar, et al.
Publicado: (2022)

Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
por: Vanderstichele, Sophie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bns6s165e2cdqagvep62b4phko